Subacromial Pain SyndromeNCT06758986
Is Gender a Factor in Patients With Subacromial Shoulder Pain?
An observational study of Subacromial Pain Syndrome, run by Kirsehir Ahi Evran Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This study aimed to investigate the effects of gender on pain, functionality, range of motion, disability level and position sense parameters in patients with subacromial shoulder pain. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Subacromial Pain Syndrome
- How many people
- 65 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Oct 2024to 17 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The study will be conducted with patients who apply to Kırşehir Ahi Evran University Physical Therapy and Rehabilitation Center with complaints of shoulder pain and who meet the inclusion criteria.
Who may be able to join
- Being between the ages of 18-65
- Being diagnosed with unilateral subacromial impingement syndrome
- Not having received steroid injections or physical therapy for shoulder problems in the last 6 months
- Having painful shoulder pain for the last 3 months
- Being willing to participate in the study
Who cannot join
- Having a rheumatic, neurological, cardiovascular, psychiatric or systemic disorder
- Having a surgical operation on the shoulder, cervical and thoracic region
- Having a neurological deficit, fracture or history of fracture in the upper extremity
- Having cervical radiculopathy
- Having communication problems
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Kirsehir Ahi Evran University
Kırşehir, Merkez, 40100
About this study
Official title: Patients With Subacromial Shoulder Pain and Gender
This study aimed to investigate the effects of gender on pain, functionality, range of motion, disability level and position sense parameters in patients with subacromial shoulder pain.
- Conditions
- Subacromial Pain Syndrome
- Keywords
- Subacromial Shoulder Pain, functionality, disability, position sense
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Study Group | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analog Scale
Measured: 20 weeks
Secondary outcomes (3)
Quick DASH
Measured: 20 weeks
SPADI
Measured: 20 weeks
The laser-pointer assisted angle reproduction test
Measured: 20 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jan 2025
- Study start25 Oct 2024
- Primary completion22 Aug 2026 (estimated)
- Study completion17 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Subacromial Pain SyndromeStudies of the same condition, open and under way.
- More trials run by Kirsehir Ahi Evran UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 65 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Atahan TURHAN, Kirsehir Ahi Evran Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06758986
- Sponsor's protocol ID
- KAEU-T.ATAHAN-010
- Status last verified
- Apr 2026
- First submitted
- 30 Dec 2024
- Last updated
- 20 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patients With Subacromial Shoulder Pain and Gender
- ClinicalTrials.gov ID
- NCT06758986
- Acronym / sponsor ID
- KAEU-T.ATAHAN-010
- Conditions
- Subacromial Pain Syndrome
- Keywords
- Subacromial Shoulder Pain, functionality, disability, position sense
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 65 participants (estimated)
- Lead sponsor
- Kirsehir Ahi Evran UniversitesiUniversity, hospital or other
- Study start
- 25 Oct 2024 (actual)
- Primary completion
- 22 Aug 2026 (estimated)
- Study completion
- 17 Sep 2026 (estimated)
- First posted
- 6 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to investigate the effects of gender on pain, functionality, range of motion, disability level and position sense parameters in patients with subacromial shoulder pain.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Study Group | – | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The study will be conducted with patients who apply to Kırşehir Ahi Evran University Physical Therapy and Rehabilitation Center with complaints of shoulder pain and who meet the inclusion criteria.
Key inclusion criteria (5 listed)
- Being between the ages of 18-65
- Being diagnosed with unilateral subacromial impingement syndrome
- Not having received steroid injections or physical therapy for shoulder problems in the last 6 months
- Having painful shoulder pain for the last 3 months
- Being willing to participate in the study
Key exclusion criteria (5 listed)
- Having a rheumatic, neurological, cardiovascular, psychiatric or systemic disorder
- Having a surgical operation on the shoulder, cervical and thoracic region
- Having a neurological deficit, fracture or history of fracture in the upper extremity
- Having cervical radiculopathy
- Having communication problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Visual Analog Scale
Time frame: 20 weeks
3 secondary outcomes
Quick DASH
Time frame: 20 weeks
SPADI
Time frame: 20 weeks
The laser-pointer assisted angle reproduction test
Time frame: 20 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Subacromial Pain Syndrome
Recruiting
Hybrid mHealth and Telerehabilitation vs Conventional Physiotherapy for Subacromial Pain Syndrome
Subacromial Pain Syndrome
Not yet recruiting
"Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial Pain"
Subacromial Impingement Syndrome
Recruiting
Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Cohort Study
Shoulder Pain Syndrome, Subacromial Pain Syndrome
Not yet recruiting
Spencer vs Positional Release Techniques for Chronic Subacromial Impingement
Chronic Subacromial Impingement Syndrome
Not yet recruiting
Effects of Different Kinesio Taping Methods in Subacromial Impingement Syndrome
Subacromial Impingement Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Subacromial Pain Syndrome, run by Kirsehir Ahi Evran Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analog Scale (time frame: 20 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.